Constipation Drug Lubiprostone Shows Promise in Improving Kidney Function in CKD Patients
Originally Published 4 months ago — by Medical Xpress
A Phase II clinical trial led by Tohoku University found that lubiprostone, a drug typically used for constipation, can help prevent the decline of kidney function in CKD patients by improving gut microbiota and mitochondrial function, offering a potential new treatment approach.
